211 related articles for article (PubMed ID: 21511019)
1. Biodegradable and temperature-responsive polyurethanes for adriamycin delivery.
Sun X; Gao H; Wu G; Wang Y; Fan Y; Ma J
Int J Pharm; 2011 Jun; 412(1-2):52-8. PubMed ID: 21511019
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone.
Zhang Y; Zhuo RX
Biomaterials; 2005 Nov; 26(33):6736-42. PubMed ID: 15935469
[TBL] [Abstract][Full Text] [Related]
3. Temperature- and pH-responsive nanoparticles of biocompatible polyurethanes for doxorubicin delivery.
Wang A; Gao H; Sun Y; Sun YL; Yang YW; Wu G; Wang Y; Fan Y; Ma J
Int J Pharm; 2013 Jan; 441(1-2):30-9. PubMed ID: 23262421
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of novel biodegradable folate conjugated polyurethanes.
Yu L; Zhou L; Ding M; Li J; Tan H; Fu Q; He X
J Colloid Interface Sci; 2011 Jun; 358(2):376-83. PubMed ID: 21470617
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
Yang Y; Hua C; Dong CM
Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
[TBL] [Abstract][Full Text] [Related]
6. Carboxylated poly(glycerol methacrylate)s for doxorubicin delivery.
Ma Y; Gao H; Gu W; Yang YW; Wang Y; Fan Y; Wu G; Ma J
Eur J Pharm Sci; 2012 Jan; 45(1-2):65-72. PubMed ID: 22085680
[TBL] [Abstract][Full Text] [Related]
7. Bioresorbable poly(ester-ether urethane)s from L-lysine diisocyanate and triblock copolymers with different hydrophilic character.
Abraham GA; Marcos-Fernández A; Román JS
J Biomed Mater Res A; 2006 Mar; 76(4):729-36. PubMed ID: 16317720
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterizations and biocompatibility of alternating block polyurethanes based on P3/4HB and PPG-PEG-PPG.
Li G; Li P; Qiu H; Li D; Su M; Xu K
J Biomed Mater Res A; 2011 Jul; 98(1):88-99. PubMed ID: 21538829
[TBL] [Abstract][Full Text] [Related]
9. The degradation and biocompatibility of pH-sensitive biodegradable polyurethanes for intracellular multifunctional antitumor drug delivery.
Zhou L; Liang D; He X; Li J; Tan H; Li J; Fu Q; Gu Q
Biomaterials; 2012 Mar; 33(9):2734-45. PubMed ID: 22236829
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, degradation, and cytotoxicity of multiblock poly(epsilon-caprolactone urethane)s containing gemini quaternary ammonium cationic groups.
Ding M; Li J; Fu X; Zhou J; Tan H; Gu Q; Fu Q
Biomacromolecules; 2009 Oct; 10(10):2857-65. PubMed ID: 19817491
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and controlled drug release from temperature-responsive poly(ether-urethane) particles based on PEG-diisocyanates and aliphatic diols.
Wang Y; Wu G; Li X; Wang Y; Gao H; Ma J
J Biomater Sci Polym Ed; 2013; 24(14):1676-91. PubMed ID: 23627737
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and biocompatibility of biodegradable elastomeric poly(ether-ester urethane)s Based on Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) and Poly(ethylene glycol) via melting polymerization.
Li Z; Yang X; Wu L; Chen Z; Lin Y; Xu K; Chen GQ
J Biomater Sci Polym Ed; 2009; 20(9):1179-202. PubMed ID: 19520007
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous drug release at different rates from biodegradable polyurethane foams.
Sivak WN; Zhang J; Petoud S; Beckman EJ
Acta Biomater; 2009 Sep; 5(7):2398-408. PubMed ID: 19398389
[TBL] [Abstract][Full Text] [Related]
14. LDI-glycerol polyurethane implants exhibit controlled release of DB-67 and anti-tumor activity in vitro against malignant gliomas.
Sivak WN; Pollack IF; Petoud S; Zamboni WC; Zhang J; Beckman EJ
Acta Biomater; 2008 Jul; 4(4):852-62. PubMed ID: 18440882
[TBL] [Abstract][Full Text] [Related]
15. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
[TBL] [Abstract][Full Text] [Related]
16. Hydrophobically modified biodegradable poly(ethylene glycol) copolymers that form temperature-responsive Nanogels.
Nagahama K; Hashizume M; Yamamoto H; Ouchi T; Ohya Y
Langmuir; 2009 Sep; 25(17):9734-40. PubMed ID: 19705882
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable thermo-sensitive nanoparticles from poly(L-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier.
Na K; Lee KH; Lee DH; Bae YH
Eur J Pharm Sci; 2006 Feb; 27(2-3):115-22. PubMed ID: 16253487
[TBL] [Abstract][Full Text] [Related]
18. Block poly(ester-urethane)s based on poly(3-hydroxybutyrate-co-4-hydroxybutyrate) and poly(3-hydroxyhexanoate-co-3-hydroxyoctanoate).
Chen Z; Cheng S; Xu K
Biomaterials; 2009 Apr; 30(12):2219-30. PubMed ID: 19167751
[TBL] [Abstract][Full Text] [Related]
19. Electrospinning and biocompatibility evaluation of biodegradable polyurethanes based on L-lysine diisocyanate and L-lysine chain extender.
Han J; Cao RW; Chen B; Ye L; Zhang AY; Zhang J; Feng ZG
J Biomed Mater Res A; 2011 Mar; 96(4):705-14. PubMed ID: 21284079
[TBL] [Abstract][Full Text] [Related]
20. Catalyst-dependent drug loading of LDI-glycerol polyurethane foams leads to differing controlled release profiles.
Sivak WN; Pollack IF; Petoud S; Zamboni WC; Zhang J; Beckman EJ
Acta Biomater; 2008 Sep; 4(5):1263-74. PubMed ID: 18440884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
